These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25440178)

  • 21. ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease.
    Gao X; Jiang Z; Yan X; Liu J; Li F; Liu P; Li J; Wei Y; Sun YE; Zhang Y; Wang C
    Cell Death Dis; 2021 Jul; 12(7):701. PubMed ID: 34262025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The non-syndromic clinical spectrums of mtDNA 3243A>G mutation.
    Shen X; Du A
    Neurosciences (Riyadh); 2021 Apr; 26(2):128-133. PubMed ID: 33814365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondria and heart disease.
    DiMauro S; Hirano M
    Curr Opin Cardiol; 1998 May; 13(3):190-7. PubMed ID: 9649942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success.
    Sallevelt SC; Dreesen JC; Drüsedau M; Spierts S; Coonen E; van Tienen FH; van Golde RJ; de Coo IF; Geraedts JP; de Die-Smulders CE; Smeets HJ
    J Med Genet; 2013 Feb; 50(2):125-32. PubMed ID: 23339111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Giant mitochondria in the myocardium of a patient with mitochondrial cardiomyopathy: transmission and 3-dimensional scanning electron microscopy.
    Kanzaki Y; Terasaki F; Okabe M; Otsuka K; Katashima T; Fujita S; Ito T; Kitaura Y
    Circulation; 2010 Feb; 121(6):831-2. PubMed ID: 20159843
    [No Abstract]   [Full Text] [Related]  

  • 27. Mitochondrial Diseases and Cardiomyopathies.
    Brunel-Guitton C; Levtova A; Sasarman F
    Can J Cardiol; 2015 Nov; 31(11):1360-76. PubMed ID: 26518446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of nitric oxide pathway parameters may depend on heteroplasmy rates of the m.3243A>G mutation.
    Finsterer J; Zarrouk-Mahjoub S
    Int J Cardiol; 2017 Feb; 229():26. PubMed ID: 27923514
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of 3243A>G mutation in mtDNA presenting as apparently idiopathic hyperCKemia.
    Rubegni A; Cardaioli E; Chini E; Da Pozzo P; Battisti C; Malandrini A; Federico A
    J Neurol Sci; 2014 Mar; 338(1-2):232-4. PubMed ID: 24468540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mitochondrial DNA mutations and cardiomyopathy].
    Ozawa T; Sugiyama S; Tanaka M
    Nihon Rinsho; 1991 Jan; 49(1):204-10. PubMed ID: 2002603
    [No Abstract]   [Full Text] [Related]  

  • 31. An unexpected cause of cardiomyopathy revealed by arrhythmias and conduction disorders in an athlete.
    Potelle C; Vantyghem MC; Verbrugge E; Coisne A; Lacroix D
    Int J Cardiol; 2015 Dec; 201():228-30. PubMed ID: 26301643
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy in mitochondrial disorders: description of an uncommon clinical case.
    Marsico F; D'Andrea C; Parente A; De Martino F; Capasso L; Raimondi F; Paolillo S; Dellegrottaglie S; Marciano C; Trimarco B; Perrone Filardi P
    Eur J Heart Fail; 2017 Sep; 19(9):1201-1204. PubMed ID: 28585276
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inherited and acquired disorders of mitochondrial DNA].
    Walker UA
    Praxis (Bern 1994); 2002 Dec; 91(49):2129-38. PubMed ID: 12523180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
    Meyers DE; Basha HI; Koenig MK
    Tex Heart Inst J; 2013; 40(4):385-94. PubMed ID: 24082366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome.
    de Laat P; Fleuren LH; Bekker MN; Smeitink JA; Janssen MC
    Mitochondrion; 2015 Nov; 25():98-103. PubMed ID: 26455484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in Molecular Genetic Study of Mitochondrial Cardiomyopathy.
    Zhuge R; Zhou R; Ni X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Jun; 39(3):438-444. PubMed ID: 28695818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies.
    Sebastiani M; Giordano C; Nediani C; Travaglini C; Borchi E; Zani M; Feccia M; Mancini M; Petrozza V; Cossarizza A; Gallo P; Taylor RW; d'Amati G
    J Am Coll Cardiol; 2007 Oct; 50(14):1362-9. PubMed ID: 17903636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial Cardiomyopathy: Molecular Epidemiology, Diagnosis, Models, and Therapeutic Management.
    Yang J; Chen S; Duan F; Wang X; Zhang X; Lian B; Kou M; Chiang Z; Li Z; Lian Q
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation.
    Lindroos MM; Borra RJ; Parkkola R; Virtanen SM; Lepomäki V; Bucci M; Virta JR; Rinne JO; Nuutila P; Majamaa K
    Brain; 2009 Dec; 132(Pt 12):3274-84. PubMed ID: 19843652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal tract involvement associated with the 3243A>G mitochondrial DNA mutation.
    Betts J; Barron MJ; Needham SJ; Schaefer AM; Taylor RW; Turnbull DM
    Neurology; 2008 Apr; 70(15):1290-2. PubMed ID: 18391161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.